moxifloxacin has been researched along with Carcinoma, Squamous Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chun, JH; Hong, SM; Kim, B; Kim, KH; Oh, BH; Park, WY | 1 |
| Benden, C; Gerber, SR; Hofbauer, GF; Inci, I; Kohler, M; Schuurmans, MM; Seifert, B; Serra, AL | 1 |
2 other study(ies) available for moxifloxacin and Carcinoma, Squamous Cell
| Article | Year |
|---|---|
High-contrast visualization of human skin cancers with combined reflectance confocal and moxifloxacin-based two-photon microscopy: An ex vivo study.
Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Eosine Yellowish-(YS); Hematoxylin; Humans; Microscopy, Confocal; Moxifloxacin; Ophthalmic Solutions; Skin Neoplasms | 2022 |
Exposure to moxifloxacin and cytomegalovirus replication is associated with skin squamous cell carcinoma development in lung transplant recipients.
Topics: Adult; Anti-Bacterial Agents; Carcinoma, Squamous Cell; Cytomegalovirus; Cytomegalovirus Infections; Female; Fluoroquinolones; Follow-Up Studies; Humans; Incidence; Lung Transplantation; Male; Middle Aged; Moxifloxacin; Retrospective Studies; Risk Factors; Skin Neoplasms; Virus Replication | 2015 |